Moneycontrol
HomeNewsBusinessMarketsNifty holds 7700 amid pressure; ITC, Adani Ports, Bharti losers
Trending Topics

Nifty holds 7700 amid pressure; ITC, Adani Ports, Bharti losers

The broader markets too were down with the BSE Midcap and Smallcap indices slipping 0.2 percent each.

April 05, 2016 / 10:44 IST
Story continues below Advertisement

Moneycontrol Bureau10:45 am Interview: NTPC board has approved investment in two solar projects with an estimated cost of Rs 3,104 crore, said AK Jha, Director-Technical at NTPC in an interview to CNBC-TV18. One of the two projects, situated in Rajasthan, has 260 MW capacity with 4 blocks of 65 MW each. The second project is located in Madhya Pradesh with 5 blocks of 50 MW each. Both projects are expected to be commissioned by March 2017, he said. Jha also added that the company plans to ramp-up its own solar capacity to 10 GW by FY22. 10:35 am Buzzing: Morgan Stanley has upgraded its rating on Biocon to overweight from underweight and raised target price to Rs 622 (from Rs 459 earlier), saying 2016 could be a turning point for the biopharmaceutical company. The stock surged more than 7 percent intraday.

The brokerage sees Biocon as a strong re-rating story given that markets have hardly priced in its biosimilar pipeline.

Story continues below Advertisement

It believes that company's (and its partner Mylan) four potential product filings each in the US and EU would add credibility to its pipeline and bring market recognition. Emerging market monetisation is under way, but the US and EU opportunities will take at least two years, according to report.

Four lead compounds of Biocon are glargine, trastuzumab, pegfilgrastim, and adalimumab.